SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
Clinical trial NCT00725478 · COMPLETED
Trial details
- NCT number
- NCT00725478
- Sponsor
- Desitin Arzneimittel GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.